HORMONAL STATUS, STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE MYOCARDIUM IN PATIENTS WITH ACROMEGALY AND ARTERIAL HYPERTENSION
https://doi.org/10.18705/1607-419X-2017-23-4-266-274
Abstract
Objective. To assess the features of the cardiovascular system and hormonal regulation of acromegaly in patients with arterial hypertension (HTN). design and methods. The study involved 66 patients with acromegaly. We assessed the interrelations between hormonal and cardiovascular parameters in acromegaly and HTN. Results. The main cardiovascular disorders in patients with acromegaly and HTN include concentric hypertrophy and left ventricular diastolic dysfunction, dilatation of the left atrium, and abnormal daily blood pressure (BP) profile. conclusions. The increased serum levels of growth hormone and insulin-like growth factor 1, duration of acromegaly and functional activity of a pituitary-adrenal axis are associated with the abnormal daily BP variability, contractile dysfunction of the longitudinal fibers of the left ventricular myocardium, reduced velocity of active relaxation of the left atrium, and left ventricular hypertrophy.
About the Authors
Yu. S. Khalimov,Russian Federation
Yury S. Khalimov, MD, PhD, DSc, Chief, Department of the Field Surgery, Military Medical Academy named after S. M. Kirov.
6 Akademician Lebedev street, St Petersburg, Russia, 194044.
S. V. Gaidouk
Russian Federation
Sergei V. Gaidouk, MD, PhD, DSc, Deputy Chief, Department of the Field Surgery, Military Medical Academy named after S. M. Kirov.
6 Akademician Lebedev street, St Petersburg, Russia, 194044.
V. S. Nikiforov
Russian Federation
Victor S. Nikiforov, MD, PhD, DSc, Associate Professor, Department of the Navy Therapy, Military Medical Academy named after S. M. Kirov.
6 Akademician Lebedev street, St Petersburg, Russia, 194044.
Yu. B. Goverdovsky
Russian Federation
Yurii B. Goverdovsky, MD, PhD, DSc, Senior Lecturer, Department of the Field Therapy, Military Medical Academy named after S. M. Kirov.
6 Akademician Lebedev street, St Petersburg, Russia, 194044.
N. A. Egorova
Russian Federation
Natalia A. Egorova, MD, PhD, Assistant, the 1st Department of Therapy (of Advanced Medical Training), Military Medical Academy named after S. M. Kirov.
6 Akademician Lebedev street, St Petersburg, Russia, 194044.
References
1. Эндокринология. Национальное руководство. Краткое издание: под ред. И. И. Дедова, Г. А. Мельниченко. М.: ГЭОТАР-Медиа, 2013. 752 с. [Endocrinology. National Guidelines. Shortened version: ed. by II Dedov, GA Melnichenko. M.: GEOTAR-Media, 2013. 752 p. In Russian].
2. Vitale G, Pivonello R, Lombardi G, Colao A. Cardiovascular complications in acromegaly. Minerva Endocrinol. 2004;29 (3):77–88.
3. Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A et al. Guidelines for acromegaly management. J Clin Endocrinol Metab. 2002;87(9):4054–4058.
4. Пронин В. С., Агаджанян С. Э., Гурова О. Ю. Акромегалия: клиника, диагностика и лечение. Врач. 2004;3:20–25. [Pronin VS, Agadjanjan SE, Gurova OU. Acromegaly: clinical features, diagnosis and treatment. Physician. 2004;3:20–25. In Russian].
5. Giulla M, Arosio M, Barelli MV, Paliotti R, Porretti S, Valentini P et al. Blood pressure-independent cardiac hypertrophy in acromegalic patients. J Hypertens. 1999;17(12 Pt 2):1965–1969.
6. Дедов И. И., Мельниченко Г. А. Акромегалия: патогенез, клиника, диагностика, дифференциальная диагностика, методы лечения: пособие для врачей. М.: УП Принт, 2012. 4–43 с. [Dedov II, Melnichenko GA. Acromegaly: pathogenesis, clinical manifestations, diagnosis, differential diagnosis, management: textbook. M.: UP Print, 2012. 4–43 p. In Russian].
7. Doga M, Bonadonna S, Gola M, Nuzzo M, Giustina A. Diagnostic and therapeutic consensus on acromegaly. J Endocrinol Invest. 2005;28(5):56–60.
8. Giustina A, Barkan FF, Casanueva A, Cavagnini F, Frohman L, Ho K et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000;85(2):526–529.
9. Barros L, Paiva I, Rodrigues D, Ruas L, Carrilho F, Carvalheiro M et al. The prevalence of hypertension in acromegaly. Acta Med Port. 1997;10(1):15–18.
10. Jaffrain-Rea ML, Moroni C, Baldelli R, Battista C, Maffei P, Terzolo M et al. Relationship between blood pressure and glucose tolerance in acromegaly. Clin Endocrinol. 2001;54(2):189–195.
11. Пронин В. С., Чаплыгина Е. В., Потешкин Ю. Е. Особенности течения и лечения артериальной гипертензии у больных акромегалией. Фарматека. 2009;17(2):83–87. [Pronin VS, Chapligina EV, Poteskin UE. Features of the course and treatment of hypertension in patients with acromegaly. Farmateka. 2009;17 (2):83–87. In Russian].
12. Марова Е. И., Пронин В. С., Агаджанян С. Э., Молитвословова Н. Н., Вакс В. В., Анциферов М. Б. и др. Медикосоциальные проблемы курации больных с акромегалией. Consilium Medicum. 2004;6(9):675–679. [Marova EI, Pronin VS, Agadzhanyan SE, Molitvoslovova NN, Vaks VV et al. Medical and social problems of treating patients with acromegaly. Consilium Medicum. 2004;6(9):675–679. In Russian].
13. Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M et al. Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology. 2008;149(7):3294–3305.
14. Новиков В. И., Новикова Т. Н., Кузьмина-Крутецкая С. Р., Ироносов В. Е. Оценка диастолической функции сердца и ее роль в развитии сердечной недостаточности. Кардиология. 2001;41(2):78–85. [Novikov VI, Novikova TN, KuzminaKrutetskaya SR, Ironosov VE. Evaluation diastolic function of the heart and its role in the development of heart failure. Kardiologiia. 2001;41(2):78–85. In Russian].
Review
For citations:
Khalimov, Yu.S., Gaidouk S.V., Nikiforov V.S., Goverdovsky Yu.B., Egorova N.A. HORMONAL STATUS, STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE MYOCARDIUM IN PATIENTS WITH ACROMEGALY AND ARTERIAL HYPERTENSION. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2017;23(4):266-274. (In Russ.) https://doi.org/10.18705/1607-419X-2017-23-4-266-274